Company News

MSI Releases New United States Software Version MyoStrain® 5.4
Myocardial Solutions, Inc. (MSI) released a new software version in the United States much like version 5.2.4 for the European Market. The updated software features...
This is some text inside of a div block.
August 1, 2022
Dr. Beatriz Lopez Melgar, Head of the New MyoStrain® Cardiac Prevention Program at Sanitas Healthcare, Addressed the MSI Board To Speak About the Importance of MyoStrain®
Dr. Melgar presented five cases where she demonstrated the clinical value of MyoStrain® over traditional metrics and current standard of care protocols. She evaluated and explained how MyoStrain provides additional information when making treatment decisions. In all five cases...
This is some text inside of a div block.
July 19, 2022
First MyoStrain® Cardio-Oncology Center Opens at La Milagrosa in Partnership with Vithas Group in Madrid
Myocardial Solutions, Inc. (MSI) announced the opening of the first MyoStrain Cardio-Oncology Center in Madrid. The Center represents a partnership between MSI and Vithas Group (Vithas), a chain of Spanish...
This is some text inside of a div block.
June 14, 2022
New European Software Release - MyoStrain® 5.2.4
Myocardial Solutions released a new software version of MyoStrain® with a primary new function feature enabling semi-auto contouring of cardiac images...
This is some text inside of a div block.
June 10, 2022
Latest MESA Article from Johns Hopkins Utilizing MyoStrain®
The latest Multi-Ethnic Study of Atherosclerosis (MESA) article evaluates the importance of intramyocardial circumferential strain in predicting risk of heart failure and hard cardiac events. This paper demonstrates the importance of...
This is some text inside of a div block.
May 13, 2022

Get Email Alerts

Subscribe to the newsletter to receive instant email notifications and alerts when news comes MyoStrain® and Myocardial Solutions, Inc.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.